DRW Holdings »

Summit Therapeutics shares owned by DRW Holdings

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by DRW Holdings from 13F filings

Historical chart of DRW Holdings investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by DRW Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by DRW Holdings

Quarter filed Position value Share count Share price at filing
2026-03-31 $219k 12k 18.96

More positions owned by DRW Holdings

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
iShares Russell 2000 Index Call Option (IWM)
NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Alphabet Inc Class A cs Call Option (GOOGL)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Tesla Motors Call Option (TSLA)
Asml Holding N V N Y Registry Shs Call Option (ASML)
Astrazeneca Plc Each Ads Representing 1/2 Of An Or Ordinary Share Call Option (AZN)
Advanced Micro Devices Call Option (AMD)
Ishares Core Msci Emkt (IEMG)
Facebook Inc cl a Call Option (META)
Vestas Put Option (VWSYF)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr China Lg-cap Etf (FXI)

View all positions for DRW Holdings

Top funds holding Summit Therapeutics

Baker Bros. Advisors
FMR
Vanguard Group
BlackRock
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
UBS Group
Geode Capital Management
Susquehanna International
D. E. Shaw & Co
Morgan Stanley
Pictet Asset Management Holding SA
Apeiron Capital
Citadel Advisors

View all funds holding Summit Therapeutics